On May 28, 2021, Pfizer and BioNTech announced that the Conditional Marketing Authorization for COMIRNATY in the European Union (EU) had been expanded to include individuals 12 to 15 years of age.

This followed the European Medicines Agencyﾒs Committee for Medicinal Products for Human Use positive opinion to authorize the vaccine in this age group.